Tumorangiogenese, Fibrosierungen in Lunge, Hand, Sehnen)
A breakthrough 2024/2025 triple-blind, placebo-controlled clinical trial (NCT06351696), published in Scientific Reports , evaluated the efficacy of oral bromelain in patients suffering from mild-to-moderate Ulcerative Colitis
It also upregulates the transcription of IL-1, IL-18, and TNF-, forming positive feedback
Individual variation in intestinal absorption and hepatic metabolism affects effective dosing across different patients
Patient selection, monitoring, and realistic timelines Even setting aside the regulatory reality, the clinical reasoning around growth-hormone secretagogues is more demanding than the marketing suggests and understanding it is essential context for any provider fielding patient questions